LuPARP: Phase 1 trial of 177Lu-PSMA-617 and olaparib in patients with metastatic castration resistant prostate cancer (mCRPC)

被引：0
|
作者：
Sandhu, Shahneen
Joshua, Anthony M.
Emmett, Louise
Crumbaker, Megan
Bressel, Mathias
Huynh, Rhonda
Banks, Patricia Diana
Wallace, Roslyn
Hamid, Anis
Inderjeeth, Andrisha Jade
Tran, Ben
Azad, Arun
Alipour, Ramin
Kong, Grace
Kumar, Aravind Ravi
Saghebi, Javad
Williams, Scott
Akhurst, Timothy J.
Hicks, Rodney J.
Hofman, Michael S.
机构：
[1] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[3] St Vincents Hosp, Sydney, NSW, Australia
[4] Peter MacCallum Canc Ctr, Ctr Biostat & Clin Trials, Melbourne, Vic, Australia
[5] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[6] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
[7] Peter MacCallum Canc Ctr, Mol Imaging & Therapeut Nucl Med, Melbourne, Vic, Australia
[8] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic, Australia
[9] Univ Melbourne, St Vincents Med Sch, Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5005
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Circulating tumor cells (CTCs) in patients with metastatic castration resistant prostate cancer (mCRPC) treated with olaparib plus 177lutetium-prostate specific membrane antigen-617 (177Lu-PSMA-617) in the LuPARP trial
    Hamid, Anis
    Gupta, Santosh
    Keerthikumar, Shivakumar
    Pasam, Anupama
    Crumbaker, Megan
    Joshua, Anthony M.
    Lam, Ernest
    Wenstrup, Rick
    Emmett, Louise
    Goode, David L.
    Hofman, Michael S.
    Sandhu, Shahneen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] PRINCE: Phase I trial of 177Lu-PSMA-617 in combination with pembrolizumab in patients with metastatic castration-resistant prostate cancer (mCRPC).
    Sandhu, Shahneen
    Joshua, Anthony M.
    Emmett, Louise
    Spain, Lavinia Anne
    Horvath, Lisa
    Crumbaker, Megan
    Anton, Angelyn
    Wallace, Roslyn
    Pasam, Anupama
    Bressel, Mathias
    Cassidy, Erin
    Banks, Patricia
    Dhiantravan, Nattakorn
    Akhurst, Timothy J.
    Kumar, Aravind Ravi
    Alipour, Ramin
    Scalzo, Mark
    Williams, Scott
    Hicks, Rodney
    Hofman, Michael S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Sun, Michael
    Niaz, Muhammad O.
    Nelson, Adlai
    Skafida, Myrto
    Niaz, Muhammad J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [4] Comment on, 177Lu-PSMA-617 in metastatic, castration-resistant prostate cancer"
    Radtke, Jan Philipp
    Albers, Peter
    Giesel, Frederik Lars
    AKTUELLE UROLOGIE, 2022, 53 (02)
  • [5] VISION trial: 177Lu-PSMA-617 for progressive metastatic castration-resistant prostate cancer
    Rohith, Gorrepati
    INDIAN JOURNAL OF UROLOGY, 2021, 37 (04) : 372 - 373
  • [6] Real world outcomes of 177Lu-PSMA-617 PSMA in a racially diverse cohort of patients with metastatic castration resistant prostate cancer (mCRPC).
    Gerke, Margo
    Marra, Angelo
    Liu, Yuan
    Muzahir, Saima
    Brown, Jacqueline T.
    Nazha, Bassel
    Berchuck, Jacob E.
    Parikh, Ravi Bharat
    Ciuro, Jordan Alana
    Hartman, Caitlin
    Mcclintock, Greta Russler
    Caulfield, Sarah
    Kucuk, Omer
    Carthon, Bradley Curtis
    Schuster, David M.
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [7] Final results of phase I/II trial of fractionated dose 177Lu-PSMA-617 for metastatic castration-resistant prostate cancer (mCRPC)
    Tagawa, S. T.
    Sun, M.
    Sartor, O.
    Thomas, C.
    Molina, A. M.
    Sternberg, C. N.
    Nanus, D. M.
    Osborne, J.
    Bander, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S645 - S645
  • [8] Phase 3 Study of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer (VISION)
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 3 - 5
  • [9] 177Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer
    Qu, Gengcuo
    Hua, Qingchu
    Li, Hongmei
    Zhang, Yu
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 152 - 153
  • [10] Phase 3 Study of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer (VISION)
    Krause, B.
    de Bono, J.
    Chi, K. N.
    Fizazi, K.
    Herrmann, K.
    Rahbar, K.
    Tagawa, S. T.
    Nordquist, L. T.
    Vaishampayan, N.
    El-Haddad, G.
    Park, C. H.
    Beer, T. M.
    Perez-Contreras, W. J.
    DeSilvio, M.
    Kpamegan, E.
    Gericke, G.
    Messmann, R. A.
    Morris, M. J.
    Sartor, O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S63 - S63
12345